Medical/Pharmaceuticals
Antengene To Present Latest Results from TORCH-2 Study of ATG-008 in Advanced Solid Tumors in Poster Discussion at ASCO 2023
* The TORCH-2 study is a Phase I/II trial of the mTORC1/2 inhibitor ATG-008 plus the Anti-PD-1 monoclonal antibody toripalimab for the treatment of patients with advanced solid tumors * The combination treatment produced an objective response rate (ORR ) of 52.4% in the advanced cervical canc...
2023-05-26 09:41
4057
Altamira Therapeutics Reports Positive Top-Line Data from Bentrio Clinical Trial in Seasonal Allergic Rhinitis
* Bentrio® meets primary efficacy endpoint in NASAR clinical trial in seasonal allergic rhinitis * Clinically relevant and statistically significant improvement in Total Nasal Symptom Score over saline nasal spray control (p = 0.012) * Bentrio efficacy and tolerability rated as "good" or "ve...
2023-05-26 08:00
6586
Invivoscribe Announces Updated Reimbursement for the LeukoStrat CDx FLT3 Mutation Assay to Select Newly Diagnosed FLT3-ITD Positive AML Patients Eligible for VANFLYTA in Japan
SAN DIEGO, May 26, 2023 /PRNewswire/ -- Invivoscribe is pleased to announce that their LeukoStrat CDxFLT3 Mutation Assay® has received updated reimbursement byJapan's Ministry of Health, Labor and Welfare (MHLW) to aid in the selection of patients with newly diagnosedFLT3-ITD positive acute my...
2023-05-26 05:00
2549
Partnership between Thermo Fisher Scientific and BRIN to Strengthen Research Infrastructure and Capabilities in Indonesia
Collaboration to enhance BRIN's scientific and innovation infrastructure and talent SINGAPORE, May 25, 2023 /PRNewswire/ -- Thermo Fisher, the world leader in serving science, has signed a Memorandum of Understanding ("MOU") with the National Research and Innovation Agency ofIndonesia (BRIN, Bad...
2023-05-25 18:04
3613
Tianlong Helps Hospitals in Thailand Detect Hepatitis Early with Molecular Diagnostic Solution
XI'AN, China, May 25, 2023 /PRNewswire/ -- Tianlong
2023-05-25 16:42
4554
AffaMed Therapeutics Announces Partner Allgenesis Reports Encouraging Preliminary Safety and Efficacy Data from the AG-73305 Phase 2a Trial for the Treatment of Diabetic Macular Edema
* AG-73305 was found to be safe and tolerable with no severe adverse effects (SAEs) after a single intravitreal injection of 0.5 mg and 1 mg in DME patients. * AG-73305 showed median improvements in Best Corrected Visual Accuity (BCVA) of 8.5 ETDRS letters with median Central Subfield Thickness...
2023-05-25 15:52
3842
Mindray Introduces Its Smart Hospital Solutions at Hospitalar 2023
SAO PAULO, Brazil, May 25, 2023 /PRNewswire/ -- Mindray, a leading global provider of medical devices and solutions, is attending one of the largest medical equipment exhibitions inSouth America, Hospitalar 2023, from May 23rd to 26th in Sao Paulo, Brazil. The company is demonstrating its latest ...
2023-05-25 15:27
3271
CGCT2023 The 3rd China Gene and Cell Therapy Innovation Forum will open on 9th-10th. June in Suzhou, China
SHANGHAI, May 25, 2023 /PRNewswire/ -- "If the 20th century was the era of drug therapy, then the 21st century is the era of cell therapy,"George Daley said, a biologist from theUSA. Cell and gene therapies (CGT), represented by CAR-T, have shown tremendous potential in many diseases, especially ...
2023-05-25 12:14
4335
Hope for knee osteoarthritis sufferers with advent of global clinical trial.
Paradigm Biopharma launches clinical trial website to support development
program for knee osteoarthritis therapy.
MELBOURNE, Australia, May 25, 2023 /PRNewswire/ -- With the launch of a new
website dedicated to their global clinical trials (https://hope4OA.com
2023-05-25 09:10
3482
Catalent Adds New Cryogenic Capabilities at Shiga, Japan, Facility to Support Clinical Supply Demand for Cell and Gene Therapy Development
SOMERSET, N.J., May 25, 2023 /PRNewswire/ -- Catalent (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it has expanded the services and capabilities at its facility in Shiga,Japan, to include the storage, kitting, and...
2023-05-25 08:00
7134
Lynk Pharmaceuticals Announces First Cohort of Psoriatic Patients Dosed with LNK01004 in Phase Ib Clinical Study
HANGZHOU, China, May 25, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that it has dosed the first cohort of psoriatic patients in a Phase Ib clinical trial of its innovative drug LNK01004. ...
2023-05-25 08:00
6460
RingConn Official Website Has Been Launched on 5.18
WILMINGTON, Del., May 25, 2023 /PRNewswire/ -- RingConn, the innovative wellness brand, is excited to announce the launch of its official website, which was successfully launched onMay 18th. This milestone signifies RingConn's commitment to providing customers with cutting-edge wellness solutions...
2023-05-25 01:00
7020
Avixgen accelerates the progress on new drug pipeline development
- Pipeline development updates on age related macular degeneration, dry eye disease and atopic dermatitis SEOUL, South Korea, May 24, 2023 /PRNewswire/ -- DxVx has released development updates on the pipelines of its recently acquired company, Avixgen. DxVx acquired about 63% stake of Avixgen, w...
2023-05-24 21:00
3941
HKBN x Mannings Pioneer FREE Pharmacist Consultations for Talents
PharmaCare Pilot Programme allows HKBN Talents to enjoy HK's leading flexible benefit package HONG KONG, May 24, 2023 /PRNewswire/ -- As flu season and COVID-19 continues, long queues are common at doctor's clinics. As a Talent-obsessed company,HKBN Group ("HKBN"), and Hong Kong's largest health...
2023-05-24 14:56
3195
Improved Overall Health, Better Sleep, and Enhanced Immunity Ranked as Top Three Health Goals by Increasingly Health-Conscious Asia Pacific Consumers - Herbalife Survey
The survey reveals 84% of Asia Pacific Consumers recognize the importance of a support group in helping them achieve health and wellness goals HONG KONG, May 24, 2023 /PRNewswire/ -- Herbalife, a premier health and wellness company and community, today released the findings of its Asia Pacific H...
2023-05-24 12:31
4910
Allgenesis Announces Encouraging Preliminary Safety and Efficacy Data from the AG-73305 Phase 2a Trial for the Treatment of Diabetic Macular Edema
* AG-73305 was found to be safe and tolerable with no severe adverse effects (SAEs) after a single intravitreal injection of 0.5 mg and 1 mg in DME patients. * AG-73305 showed median improvements in Best Corrected Visual Accuity (BCVA) of 8.5 ETDRS letters with median Central Subfield Thickness...
2023-05-24 10:24
2495
Chula Researchers Discover "Highly Effective Antibodies against COVID-19," Leading to "COVITRAP Nasal Spray" to Curb Infection at the Start
BANGKOK, May 24, 2023 /PRNewswire/ -- A research team at the Center of Excellence in Systems Biology, Faculty of Medicine,Chulalongkorn University, has identified "highly effective antibodies against COVID-19" from the human body. These antibodies have been developed into an innovation called "C...
2023-05-24 10:00
3911
Infinitus Meets 520 Social Responsibility Day Goal for 5 Years, Promoting Healthy Living
GUANGZHOU, China, May 24, 2023 /PRNewswire/ -- On May 20, Infinitus hosted the 520 Infinitus Social Responsibility Day for the 5th consecutive year at Infinitus Plaza inGuangzhou, centered around this year's theme, "You and I Together for a Healthy Lifestyle". The event, broadcasted live online, ...
2023-05-24 08:00
3639
ESOC 2023: AI tool outperforms human emergency call handlers in identifying stroke, new study shows
MUNICH, May 24, 2023 /PRNewswire/ -- Researchers from Denmark have developed a new artificial intelligence (AI) framework to address the number of strokes that go unrecognised by human emergency call handlers. The framework outperformed emergency call handlers in recognising stroke for both sexes...
2023-05-24 06:00
3548
Fortis Healthcare recognized for its contribution in positioning India as the Medical Tourism Hub; Conferred with 7 Awards
Fortis was awarded by Advantage Health Care India - an International Summit, which was organized from 26th - 28th April 2023 NEW DELHI, May 23, 2023 /PRNewswire/ -- India's leading hospital chain, Fortis Healthcare has been recognized for its contribution in positioning India as the preferred me...
2023-05-23 20:34
3344
Week's Top Stories
Most Reposted
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
[Picked up by 310 media titles]
2026-10-13 10:00
Agoda and Emerging Travel Group Enter Strategic Partnership
[Picked up by 292 media titles]
2026-10-15 16:00Food & Hospitality Asia 2027 Redefining Excellence: The Premier Platform for Food & Beverage and Hospitality Innovation
[Picked up by 281 media titles]
2026-10-15 10:00Leading Asian DMC Discova to Attend ITB Asia 2026
[Picked up by 279 media titles]
2026-10-15 12:59
DayOne Upsizes Malaysia Financing to US$7.2 Billion; Total Billings Surpass 1GW and Bookings Reach 2.3GW
[Picked up by 270 media titles]
2026-10-14 18:01Most Read
Amap and Sands China mark the delivery of the first Tutu robots, with expected indoor navigation and 3D resort previews
2026-10-10 16:43
16690
Sonilo Raises $11M to Build the AI-Native Audio Stack for Video
2026-10-15 00:00
16189
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
2026-10-13 10:00
14238
Zoomlion Expands Mining Machinery Business as International Revenue Grows
2026-10-10 16:58
8288
